Nitric oxide induces [Ca2+]i oscillations in pituitary GH3 cells: involvement of IDR and ERG K+ currents

Am J Physiol Cell Physiol. 2006 Jan;290(1):C233-43. doi: 10.1152/ajpcell.00231.2005. Epub 2005 Oct 5.

Abstract

The role of nitric oxide (NO) in the occurrence of intracellular Ca2+ concentration ([Ca2+]i) oscillations in pituitary GH3 cells was evaluated by studying the effect of increasing or decreasing endogenous NO synthesis with L-arginine and nitro-L-arginine methyl ester (L-NAME), respectively. When NO synthesis was blocked with L-NAME (1 mM) [Ca2+]i, oscillations disappeared in 68% of spontaneously active cells, whereas 41% of the quiescent cells showed [Ca2+]i oscillations in response to the NO synthase (NOS) substrate L-arginine (10 mM). This effect was reproduced by the NO donors NOC-18 and S-nitroso-N-acetylpenicillamine (SNAP). NOC-18 was ineffective in the presence of the L-type voltage-dependent Ca2+ channels (VDCC) blocker nimodipine (1 microM) or in Ca2+-free medium. Conversely, its effect was preserved when Ca2+ release from intracellular Ca2+ stores was inhibited either with the ryanodine-receptor blocker ryanodine (500 microM) or with the inositol 1,4,5-trisphosphate receptor blocker xestospongin C (3 microM). These results suggest that NO induces the appearance of [Ca2+]i oscillations by determining Ca2+ influx. Patch-clamp experiments excluded that NO acted directly on VDCC but suggested that NO determined membrane depolarization because of the inhibition of voltage-gated K+ channels. NOC-18 and SNAP caused a decrease in the amplitude of slow-inactivating (IDR) and ether-à-go-go-related gene (ERG) hyperpolarization-evoked, deactivating K+ currents. Similar results were obtained when GH3 cells were treated with L-arginine. The present study suggests that in GH3 cells, endogenous NO plays a permissive role for the occurrence of spontaneous [Ca2+]i oscillations through an inhibitory effect on IDR and on IERG.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Animals
  • Arginine / pharmacology
  • Calcium Signaling / physiology*
  • Cell Line
  • Enzyme Inhibitors / pharmacology
  • Ether-A-Go-Go Potassium Channels / metabolism*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / metabolism*
  • Nitric Oxide Donors / pharmacology
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / metabolism
  • Nitroprusside / pharmacology
  • Nitroso Compounds / pharmacology
  • Pituitary Gland / cytology*
  • Pituitary Gland / metabolism
  • Potassium / metabolism*
  • Rats
  • S-Nitroso-N-Acetylpenicillamine / pharmacology
  • Software Design

Substances

  • Enzyme Inhibitors
  • Ether-A-Go-Go Potassium Channels
  • NOC 18
  • Nitric Oxide Donors
  • Nitroso Compounds
  • Nitroprusside
  • Nitric Oxide
  • S-Nitroso-N-Acetylpenicillamine
  • Arginine
  • Nitric Oxide Synthase
  • Potassium
  • NG-Nitroarginine Methyl Ester